Your browser doesn't support javascript.
loading
Development of a Translational Exposure-Bracketing Approach to Streamline the Development of Hormonal Contraceptive Drug Products.
Cicali, Brian; Da Silva, Lais; Sarayani, Amir; Lingineni, Karthik; Pressly, Michelle; Kim, Soyoung; Wendl, Thomas; Hoechel, Joachim; Vozmediano, Valvanera; Winterstein, Almut G; Brown, Joshua D; Schmidt, Stephan; Cristofoletti, Rodrigo.
Afiliación
  • Cicali B; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Da Silva L; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Sarayani A; Department of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation & Safety, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Lingineni K; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Pressly M; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Kim S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Wendl T; Bayer AG Pharmaceuticals,, Berlin, Germany.
  • Hoechel J; Bayer AG Pharmaceuticals,, Berlin, Germany.
  • Vozmediano V; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Winterstein AG; Department of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation & Safety, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Brown JD; Department of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation & Safety, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Schmidt S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Cristofoletti R; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
Clin Pharmacol Ther ; 112(4): 909-916, 2022 10.
Article en En | MEDLINE | ID: mdl-35723889

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Progestinas / Citocromo P-450 CYP3A Tipo de estudio: Guideline Límite: Female / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Progestinas / Citocromo P-450 CYP3A Tipo de estudio: Guideline Límite: Female / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos